The Life-Extension Episode With Dr. Matt Kaeberlein | The Tim Ferriss Show

Tim Ferriss interviews aging biologist Dr. Matt Kaeberlein about what is real versus hype in longevity science. Kaeberlein explains the biology of aging, why he focuses on rapamycin (and how he used it to self-treat his own frozen shoulder), and the Dog Aging Project's clinical trial testing rapamycin in companion dogs. He walks through candidate interventions like alpha-ketoglutarate, spermidine, urolithin A, metformin and NAD precursors, while debunking the resveratrol and sirtuin stories. The conversation stresses healthspan over raw lifespan, the dangers of short-lived controls in studies, and the field's underfunding and poor science communication.

• Kaeberlein treated his own frozen shoulder with a 10-week course of rapamycin, regaining about 90 percent range of motion with the pain gone and not returning, after physical therapy had failed.
  00:19:17
• In mice, rapamycin doesn't just slow aging but functionally reverses declines: the aged immune system responds to vaccines again, the aged heart works better, and eight weeks of treatment reversed periodontal disease and regrew bone around teeth.
  00:32:16
• Analyzing roughly 25,000 dogs in the Dog Aging Project, dogs fed once a day had lower risk in six of ten age-related disease categories than dogs fed more often, with all ten trending the right direction (though observational, not proven causal).
  01:13:08
• Kaeberlein's lab showed resveratrol does NOT activate sirtuins in living cells; the famous 2003 result only worked because the test peptide had an artificial chemical group, and a large meta-analysis now finds resveratrol has essentially zero effect on aging.
  01:59:37
• Hundreds of millions of dollars chasing mammalian sirtuins as aging regulators have 'completely fallen flat'; the field was led down this path with never any solid evidence to support it.
  01:51:20
• A halted trial (resTORbio) of a six-week rapamycin-derivative course was later found to reduce significant infections from several viruses, including a coronavirus, by around 50 percent over the following year, a decision made in November 2019, months before COVID.
  01:32:40
• Curing all cancer would add only about three years to a 50-year-old's life expectancy, and heart disease about the same; targeting the underlying biology of aging offers far greater potential gains.
  01:20:50

• Kaeberlein earned undergraduate degrees in both mathematics and biochemistry and nearly pursued math before choosing biology.
  00:11:30
• The Dog Aging Project is the largest longitudinal study of aging in any animal, following more than 40,000 companion dogs across the US.
  00:12:00
• Rapamycin (clinically called sirolimus, brand Rapamune) was FDA-approved around 1999, mainly to prevent organ transplant rejection.
  00:29:41
• Many anti-aging drugs from the NIA Interventions Testing Program extend lifespan in only one sex, tending to favor males.
  00:53:29
• The largest lifespan extension shown with rapamycin in mice is about a 25 percent increase.
  00:48:20
• In mice, an estimated 60 to 90 percent of deaths are due to cancer; in dogs, cancer is also a leading killer (euthanasia being the technical leading cause of death).
  01:00:08
• Aging biology research gets about 350 million dollars a year from the NIH versus roughly 6 billion for cancer; a Saudi-funded foundation has pledged about 1 billion a year going forward.
  01:18:48
• Black-6 mice normally live around 900 days, yet many published 'lifespan-extending' studies use sick controls living only 650 days, inflating percentage effects.
  01:37:49
• Resveratrol is one of the 'dirtiest' drugs known, binding many targets, and has repeatedly fallen out of pharmaceutical screens.
  01:54:57
• Acarbose and 17-alpha-estradiol extend male mouse lifespan; the latter works only in males via an unknown mechanism.
  02:01:41

Books, products and media the guest or host genuinely endorsed here — with the buy link.

Affiliate link — we may earn a commission at no extra cost to you.